Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06941610 · ClinicalTrials.gov registry record · NA

An Evaluation of the Erchonia Laser As a Non-Invasive Treatment to Improve the Appearance of Skin Laxity

A NA study of Skin Laxity, sponsored by Erchonia Corporation.

Recruiting
Registry status
NA
Development phase
35
Enrollment target
1
Study location

NCT06941610 is a NA study of Skin Laxity that is actively recruiting participants, run by Erchonia Corporation. The registered enrollment target is 35 participants, below the 187-participant average among 10 other Skin Laxity trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06941610, a NA study of Skin Laxity, is actively recruiting participants, sponsored by Erchonia Corporation.

RECRUITING
Registry status
NA
Development phase
35 participants
Enrollment target
1
Study location

Study Summary

The purpose of this clinical study is to determine the effectiveness of the Erchonia® GVS in improving the appearance of skin laxity on the abdominal region.

Conditions Studied

Interventions

  • DEVICE Erchonia GVS Laser

Study Locations (1)

Florida

  • Cesar A. Lara M.D. Weight Loss & Wellness - Dunedin

Trial Details

FieldValue
Enrollment Target 35 participants
Start Date 2025-05-30
Est. Completion 2026-11-01
Phase NA

Sponsor

Erchonia Corporation

34 total trials

What the Registry Record Tells You About NCT06941610

The ClinicalTrials.gov registry entry for NCT06941610 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 187-participant average among 10 other Skin Laxity trials with a reported enrollment target (81% lower). The listed sponsor is Erchonia Corporation, which has 34 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Skin Laxity appearing as the primary indexed condition, and to 1 intervention - of which Erchonia GVS Laser is the first listed.

NCT06941610 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT06941610 about?

NCT06941610 is a clinical study titled "An Evaluation of the Erchonia Laser As a Non-Invasive Treatment to Improve the Appearance of Skin Laxity". The purpose of this clinical study is to determine the effectiveness of the Erchonia® GVS in improving the appearance of skin laxity on the abdominal region.

What is the current status of trial NCT06941610?

This trial is currently recruiting. It is a NA study. The enrollment target is 35 participants. The study started on 2025-05-30. Estimated completion is 2026-11-01.

What conditions does trial NCT06941610 study?

This clinical trial studies the following conditions: Skin Laxity.

What interventions are being tested in trial NCT06941610?

The interventions under investigation include: Erchonia GVS Laser (DEVICE).

Who is sponsoring clinical trial NCT06941610?

This trial is sponsored by Erchonia Corporation, which has 34 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06941610 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Skin Laxity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.